Synlett 2004(6): 951-954  
DOI: 10.1055/s-2004-820042
LETTER
© Georg Thieme Verlag Stuttgart · New York

Aerobic Ru-Catalyzed Epoxidations in Fluorous Biphasic System Using New Fluorous Benzimidazolic Ligands

Gianna Ragagnin, Paul Knochel*
Department Chemie, Ludwig-Maximilians-Universität München, Butenandtstrasse 5-13, 81377 München, Germany
Fax: +49(89)218077680; e-Mail: Paul.Knochel@cup.uni-muenchen.de;
Further Information

Publication History

Received 26 November 2003
Publication Date:
25 March 2004 (online)

Abstract

An efficient ruthenium catalyzed fluorous biphasic ­epoxidation of alkenes with oxygen in the presence of a pyridine-benzimidazole ligand bearing perfluorinated ponytails is described. Excellent yields and reaction rates were obtained and the fluorous phase could be recycled up to ten times without any loss of activity.

10

Main isomer 7: 1-5% of the 5,7-diiodo isomer was also detected.

11

Analytical data for C29H9N3F34 (1): 1H NMR (400 MHz, CDCl3): δ = 8.73 (d, J = 4 Hz, 1 H), 8.51 (d, J = 7.8 Hz, 1 H), 7.89 (td, J = 7.8 and 1.6 Hz, 1 H), 7.87 (s, 1 H), 7.73 (s, 1 H), 7.42 (m, 1 H), 4.40 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 148.6, 147.7, 137.2, 136.1, 136.0, 122.0-113.0(bm), 32.3, 28.7 ppm. 19F NMR (400 MHz, CDCl3): δ = -79.7 (s, 6 F), -107.4 (m, 4 F), -120.1 (s, 8 F), -120.7 (s, 8 F), -121.6 (s, 4 F), -125.0 (s, 4 F) ppm. IR (KBr, pellets): 3440 (m), 2922 (w), 2856 (w), 1635 (w), 1208 (s), 1150 (s), 666 (w) cm-1. MS (EI, 70 eV): m/e (rel. int.) = 1045 (100), 1025 (19), 967 (1), 706 (6), 676 (23), 626 (6), 338 (2), 307 (3), 258 (7), 168 (1). HRMS: calcd 1045.0254; found: 1045.0230. Mp 134 °C.
Analytical data for C33H17N3F34 (1a): 1H NMR (400 MHz, CDCl3): δ = 8.68 (d, J = 3.6 Hz, 1 H), 8.37 (d, J = 6.0 Hz, 1 H), 7.84 (td, J = 5.4 and 0.9 Hz, 1 H), 7.34 (m, 1 H), 7.15 (s, 1 H), 6.98 (s, 1 H), 4.25 (s, 3 H), 3.37 (m, 2 H), 3.06 (m, 2 H), 2.73 (m, 2 H), 2.45 (m, 2 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 149.7, 149.6, 147.5, 139.5, 136.7, 135.8, 133.7, 130.4, 123.9, 123.8, 122.6, 121.6, 122.0-108.0 (m), 107.0, 32.7 (t), 31.8, 30.5 (t), 28.7 ppm. 19F NMR (400 MHz, CDCl3): δ = -79.7 (s, 6 F), -113.4 (s, 4 F), -120.5 (s, 4 F), -120.6 (s, 8 F), -120.8 (s, 4 F), -121.6 (s, 4 F), -122.3 (s, 4 F), -125.0 (s, 4 F). IR (KBr, pellets): 2961 (w), 1591 (w), 1470 (w), 1204 (s), 1150 (s), 724 (w), 659 (w) cm-1. MS (EI, 70 eV): m/e (rel. int.) = 1101 (100), 1082 (24), 732 (55), 682 (23), 668 (25), 355 (2), 334 (3), 281 (4), 207 (3). HRMS: calcd.1101.088; found: 1101.044. Mp 104 °C.

12

Typical Procedure: Preparation of cyclooctene oxide (3a):
A 50 mL Schlenk tube, equipped with a stirrer and a O2-inlet was charged with the fluorous benzimidazole 1 (52.0 mg, 50 µmol, 2 mol%) dissolved in perfluorooctyl bromide (2.5 mL), and RuCl3·xH2O (36% Ru, 7 mg, 25 µmol, 1 mol%) dissolved in a few drops of acetone leading to a red solution. After stirring for 0.5 h, a solution of cis-cyclooctene (220 mg, 2.0 mmol) and i-PrCHO (288 mg, 4.0 mmol, 2 equiv) in chlorobenzene (2 mL) was added. The biphasic reaction mixture was stirred at 40 °C while a gentle stream of oxygen from a balloon was passing. The color of the reaction mixture changes from red to deep blue within 15 min. At the end of the reaction, the mixture was cooled to 10 °C, the organic layer was decanted and the fluorous phase was washed with chlorobenzene (4 × 2 mL). The chlorobenzene is removed in vacuo and the residue diluted with CH2Cl2 (20 mL). The organic phase is treated with cold NaOH (0.1 M, 20 mL) and washed with brine. After drying (MgSO4), filtration and evaporation of the solvent in vacuo the crude product was purified by flash chromatography (eluent: Et2O-pentane), yielding 224 mg (89%) of analytically pure cyclooctene oxide. The blue fluorous phase containing the Ru-catalyst was used directly for further reaction runs without loss of activity.